Opus Genetics, Inc. Cash Equivalents, at Carrying Value
Opus Genetics, Inc. (IRD) had Cash Equivalents, at Carrying Value of $17.02 million as of 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashEquivalentsAtCarryingValue · last filed 2022-08-12
- 2022-06-30: Cash Equivalents, at Carrying Value $17.02M.
- 2022-03-31: Cash Equivalents, at Carrying Value $19.25M.
- 2021-12-31: Cash Equivalents, at Carrying Value $24.53M.
- 2021-09-30: Cash Equivalents, at Carrying Value $22.25M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2022-06-30 | $17.02M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $19.25M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $24.53M 10-Q · filed 2022-08-12 |
| 2021-09-30 | $22.25M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $24.23M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $10.60M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $16.40M 10-K · filed 2022-03-24 |
| 2019-12-31 | $1.54M 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |